Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine

NCT00853749 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Pneumococcal Disease

Interventions

BIOLOGICAL: 13-valent pneumococcal conjugate vaccine (13vPnC)
PROCEDURE: Blood draw

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer

Collaborators

[object Object]